Aaron Berger

Aaron Berger serves as the Interim Head of Peri & Post Approval Services for UBC. In this role, he works towards the strategic design and execution of late stage clinical trials and observational research that will generate powerful, real world evidence of product effectiveness, safety, and value.

Aaron joined the UBC team in 2003 and has since served in a range of diverse roles leveraging global capabilities in the execution of peri- and post-marketing product development programs and real world evidence generation. He has supported the development of RWD / RWE architectures and solutions to drive greater insight into the safety profile and value proposition of medicines.